![]() |
市場調查報告書
商品編碼
2032518
光聲成像市場報告:按產品、適應症、應用、最終用途和地區分類(2026-2034 年)Photoacoustic Imaging Market Report by Product, Indication, Application, End Use, and Region 2026-2034 |
||||||
2025年全球光聲成像市場規模達1.231億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到3.535億美元,2026年至2034年的複合年成長率(CAGR)為12.06%。這一市場成長的主要驅動力是混合成像技術的持續進步、光聲成像在腫瘤學領域用於高解析度腫瘤可視化的日益普及,以及為提高診斷準確性和探索新的臨床應用而加大研發投入。
光聲成像(也稱為光聲學成像)是一種非侵入性成像技術,無需使用電離輻射即可獲得生物組織的影像。它是一種基於光聲效應的混合成像方式,將吸收的光能轉換為聲能。與傳統成像技術相比,光聲成像具有許多優勢,包括高滲透性深度、高影像解析度、無有害電離輻射以及可進行深度分子標靶成像。此技術可用於檢測脂質、黑色素和血紅蛋白濃度、水和氧飽和度以及天然存在的生色團等生理特性。此外,它也廣泛應用於腫瘤定位、腦功能評估、皮膚黑色素瘤檢測和高鐵血紅蛋白測量。因此,光聲成像正引起全球的廣泛關注。
成像系統的持續技術進步
根據光聲成像市場報告顯示,由於成像技術的不斷發展,市場需求正顯著成長。更先進的混合成像系統將光聲成像與光學和超音波方法相結合,從而實現更好的功能成像和更高的解析度。這些進步使得即時觀察生物組織成為可能,並具有更好的穿透深度和對比度,尤其是在腫瘤學和心血管醫學領域。先進的軟體和演算法能夠顯著提升影像重建和分析能力,並廣泛應用。近期研究引進了基於矽光電儀(LDV)的非接觸式光聲成像方法,其性能優於現有商用系統,並能重建精確的2D影像。這些技術創新提高了系統的多功能性,加速了其在科學研究和臨床領域的應用,並推動了整體市場成長。
在腫瘤學領域不斷擴展的應用
這些成像解決方案在腫瘤學領域的應用不斷拓展,也推動了光聲成像市場的成長。這項技術能夠以高解析度成像腫瘤血管結構和組織氧合水平,對於癌症早期檢測、療效追蹤和手術指導都極為有用。對於需要重複掃描的患者而言,非侵入性光聲成像提供了比CT和MRI等傳統影像方法更安全的選擇。隨著全球癌症發生率的上升,人們對更精準、更即時的診斷設備的需求也日益成長。
增加研發投資
隨著研發投入的不斷增加,市場正快速擴張,光聲成像的市佔率也隨之擴大。企業和研究機構正致力於開發影像系統,並探索新的臨床應用,以改善患者預後和診斷準確性。快速開發新型造影劑以提升特定組織和疾病的影像效果,也是這些努力的目標之一。除了核心技術的進步,政府資助以及產學研之間的策略合作也進一步推動了該領域的持續創新。因此,研發工作正在拓展光聲成像的應用範圍,刺激各個醫療和研究領域的需求,並加強對光聲成像市場的分析。
The global photoacoustic imaging market size reached USD 123.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 353.5 Million by 2034, exhibiting a growth rate (CAGR) of 12.06% during 2026-2034. The market growth is primarily driven by the ongoing advancements in hybrid imaging technologies, the expanding use of photoacoustic imaging in oncology for high-resolution tumor visualization, and rising investments in research and development to improve diagnostic accuracy and explore new clinical applications.
Photoacoustic imaging, also known as optoacoustic imaging, is a non-invasive biomedical imaging technique that captures images of biological tissues without using ionizing radiation. It is a hybrid modality that functions on the photoacoustic effect, wherein absorbed optical energy is converted into acoustic energy. It offers various advantages over conventional imaging techniques, including high penetration, depth, and image resolution, no harmful ionizing radiation, and molecular targeting at imaging depth. It is employed in detecting physiological properties and naturally occurring chromophores, such as lipids, melanin, hemoglobin concentration, and water and oxygen saturation. Besides this, it is extensively used for tumor mapping, functioning of the brain, detecting skin melanoma, and measuring methemoglobin. As a result, photoacoustic imaging is gaining immense traction across the globe.
Continual Technological Advancements in Imaging Systems
According to the photoacoustic imaging market, the demand is increasing significantly due to ongoing developments in imaging technology. More advanced hybrid imaging systems are offering improved functional imaging and higher resolution through the combination of photoacoustic imaging with optical and ultrasonic approaches. These developments render it possible to visualize biological tissues in real time with better depth penetration and contrast, especially for oncology and cardiovascular applications. Improved image reconstruction and interpretation through advanced software and algorithms are being preferred by the masses. A recent study introduced a non-contact photoacoustic method using a silicon photonics based LDV, which outperformed commercial systems and reconstructed accurate 2D images. These technological innovations are making the systems more versatile, driving their adoption in both research and clinical settings, and supporting the overall market growth.
Growing Application in Oncology
The increasing application of these imaging solutions in oncology is also contributing to the photoacoustic imaging market growth. Its ability to provide high-resolution images of tumor vasculature and tissue oxygenation levels renders the technique invaluable for early cancer detection, tracking treatment response, and guiding surgery. For patients who need repeated scans, non-invasive photoacoustic imaging is a safer option than conventional imaging modalities such as CT and MRI. More precise, real-time diagnostic instruments are becoming increasingly popular as the prevalence of cancer rises worldwide.
Increasing Research and Development Investments
The market is expanding more quickly as a result of the growing research and development (R&D) expenditures, thereby augmenting the photoacoustic imaging market share. In order to improve patient outcomes and diagnostic accuracy, businesses and research institutes are concentrating on developing imaging systems and investigating novel clinical applications. The rapid development of novel contrast agents enhancing the imaging of certain tissues and disorders is another goal of these efforts. In addition to the advancement of core technologies, ongoing innovation in this field is also being further supported by government financing and strategic collaborations between industry and academics. Consequently, research and development endeavors are broadening the possible uses of photoacoustic imaging, propelling demand in diverse medical and research domains, and augmenting photoacoustic imaging market analysis.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.